Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 25 | 2003 | 20776 | 0.220 |
Why?
|
| Enteritis | 1 | 2003 | 164 | 0.200 |
Why?
|
| Intestine, Small | 4 | 2003 | 1218 | 0.200 |
Why?
|
| Intestinal Diseases | 2 | 2002 | 505 | 0.170 |
Why?
|
| Liver Diseases | 7 | 1997 | 1305 | 0.160 |
Why?
|
| Audiovisual Aids | 1 | 1999 | 99 | 0.150 |
Why?
|
| Oxides | 6 | 1991 | 403 | 0.150 |
Why?
|
| Liver Neoplasms | 15 | 1997 | 4363 | 0.140 |
Why?
|
| Colonic Diseases | 2 | 2003 | 204 | 0.140 |
Why?
|
| Radiology | 3 | 1999 | 2104 | 0.140 |
Why?
|
| Peer Review | 1 | 1999 | 219 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2003 | 1506 | 0.140 |
Why?
|
| Intestinal Obstruction | 3 | 1995 | 433 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 30 | 1994 | 36861 | 0.120 |
Why?
|
| Adipose Tissue | 2 | 2003 | 3335 | 0.120 |
Why?
|
| Pentetic Acid | 4 | 1993 | 209 | 0.120 |
Why?
|
| Anus Diseases | 1 | 1993 | 54 | 0.110 |
Why?
|
| Ferric Compounds | 8 | 1992 | 377 | 0.100 |
Why?
|
| Organometallic Compounds | 4 | 1993 | 648 | 0.100 |
Why?
|
| Polylysine | 1 | 1993 | 131 | 0.100 |
Why?
|
| Hemangioma | 4 | 1997 | 727 | 0.090 |
Why?
|
| Gadolinium DTPA | 4 | 1993 | 823 | 0.090 |
Why?
|
| Iron | 6 | 1991 | 1813 | 0.090 |
Why?
|
| Gadolinium | 4 | 1993 | 965 | 0.090 |
Why?
|
| Cross-Linking Reagents | 1 | 1993 | 692 | 0.090 |
Why?
|
| Adrenal Glands | 1 | 1993 | 557 | 0.090 |
Why?
|
| Contrast Media | 13 | 1997 | 5334 | 0.080 |
Why?
|
| Cysts | 4 | 1997 | 685 | 0.080 |
Why?
|
| Rats, Inbred Strains | 9 | 1991 | 2087 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 1197 | 0.070 |
Why?
|
| Internet | 1 | 1999 | 3112 | 0.070 |
Why?
|
| Specialization | 1 | 1991 | 780 | 0.070 |
Why?
|
| Radiography, Interventional | 1 | 1993 | 1131 | 0.070 |
Why?
|
| Mesenteric Vascular Occlusion | 4 | 1975 | 93 | 0.070 |
Why?
|
| Colon | 3 | 2003 | 1804 | 0.060 |
Why?
|
| Ferrosoferric Oxide | 6 | 1991 | 348 | 0.060 |
Why?
|
| Colitis | 4 | 1998 | 1244 | 0.060 |
Why?
|
| Receptors, Immunologic | 4 | 1992 | 1418 | 0.060 |
Why?
|
| Gases | 2 | 1995 | 204 | 0.060 |
Why?
|
| Embolism, Air | 1 | 2003 | 110 | 0.050 |
Why?
|
| Lymph Nodes | 3 | 1991 | 3473 | 0.050 |
Why?
|
| Diverticulitis, Colonic | 2 | 2002 | 139 | 0.050 |
Why?
|
| Medicine | 1 | 1991 | 947 | 0.050 |
Why?
|
| Rats, Inbred F344 | 3 | 1993 | 825 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 1993 | 2238 | 0.050 |
Why?
|
| Algorithms | 2 | 2002 | 14199 | 0.050 |
Why?
|
| Colchicine | 1 | 2003 | 257 | 0.050 |
Why?
|
| Gout Suppressants | 1 | 2003 | 177 | 0.050 |
Why?
|
| Rats | 13 | 1993 | 23847 | 0.050 |
Why?
|
| Ileum | 1 | 2003 | 558 | 0.050 |
Why?
|
| Diagnosis, Differential | 10 | 2003 | 13020 | 0.050 |
Why?
|
| Bone Marrow | 1 | 1991 | 2935 | 0.050 |
Why?
|
| Injections, Intravenous | 3 | 1991 | 1379 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1997 | 9081 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 1990 | 189 | 0.040 |
Why?
|
| Liver | 9 | 1992 | 7579 | 0.040 |
Why?
|
| Kidney Calculi | 1 | 2003 | 469 | 0.040 |
Why?
|
| ROC Curve | 3 | 1997 | 3629 | 0.040 |
Why?
|
| Adenocarcinoma | 5 | 1993 | 6401 | 0.040 |
Why?
|
| Appendicitis | 3 | 2002 | 689 | 0.030 |
Why?
|
| Cecum | 2 | 1997 | 231 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 5 | 1994 | 5443 | 0.030 |
Why?
|
| Mesenteric Arteries | 3 | 1975 | 178 | 0.030 |
Why?
|
| Tissue Distribution | 4 | 1993 | 2299 | 0.030 |
Why?
|
| Magnetite Nanoparticles | 3 | 1991 | 313 | 0.030 |
Why?
|
| Dextrans | 3 | 1991 | 574 | 0.030 |
Why?
|
| Biopsy, Needle | 3 | 1989 | 1627 | 0.030 |
Why?
|
| Particle Size | 4 | 1991 | 1652 | 0.030 |
Why?
|
| Pancreas | 4 | 1990 | 1700 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 1993 | 220 | 0.030 |
Why?
|
| Rhodamines | 1 | 1993 | 178 | 0.030 |
Why?
|
| Abdomen, Acute | 3 | 1985 | 122 | 0.030 |
Why?
|
| South America | 1 | 1993 | 180 | 0.030 |
Why?
|
| Indium Radioisotopes | 1 | 1993 | 116 | 0.030 |
Why?
|
| Ischemia | 4 | 1975 | 1900 | 0.030 |
Why?
|
| Economics | 1 | 1993 | 141 | 0.030 |
Why?
|
| Gels | 1 | 1993 | 422 | 0.030 |
Why?
|
| Intestines | 3 | 2003 | 1911 | 0.020 |
Why?
|
| Asialoglycoprotein Receptor | 4 | 1992 | 36 | 0.020 |
Why?
|
| Splenic Neoplasms | 2 | 1988 | 97 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 1991 | 506 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1998 | 1281 | 0.020 |
Why?
|
| Pancreatitis | 2 | 1988 | 1087 | 0.020 |
Why?
|
| Humans | 43 | 2003 | 768887 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 1991 | 2018 | 0.020 |
Why?
|
| Barium Sulfate | 3 | 1997 | 180 | 0.020 |
Why?
|
| Middle Aged | 22 | 2003 | 223740 | 0.020 |
Why?
|
| Stainless Steel | 1 | 1989 | 79 | 0.020 |
Why?
|
| Muscles | 1 | 1993 | 1582 | 0.020 |
Why?
|
| Feces | 1 | 1995 | 1511 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 2445 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2003 | 9384 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1993 | 1998 | 0.020 |
Why?
|
| Rectum | 1 | 1993 | 900 | 0.020 |
Why?
|
| Image Enhancement | 2 | 1990 | 2898 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1989 | 287 | 0.020 |
Why?
|
| Accreditation | 1 | 1991 | 477 | 0.020 |
Why?
|
| Certification | 1 | 1991 | 420 | 0.020 |
Why?
|
| Aortography | 3 | 1975 | 422 | 0.020 |
Why?
|
| Liver Abscess | 1 | 1988 | 81 | 0.020 |
Why?
|
| Colonic Neoplasms | 4 | 2003 | 2543 | 0.020 |
Why?
|
| Male | 26 | 2003 | 365249 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1993 | 2234 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 1988 | 245 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 1990 | 2336 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 6131 | 0.020 |
Why?
|
| Pancreatic Diseases | 1 | 1988 | 353 | 0.020 |
Why?
|
| Needles | 1 | 1989 | 461 | 0.020 |
Why?
|
| Animals | 13 | 1993 | 169408 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 1990 | 825 | 0.020 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1984 | 52 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1994 | 6346 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 4774 | 0.010 |
Why?
|
| Abscess | 1 | 1988 | 606 | 0.010 |
Why?
|
| Hemangioma, Cavernous | 3 | 1990 | 107 | 0.010 |
Why?
|
| Abdomen | 1 | 1989 | 1137 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1993 | 1483 | 0.010 |
Why?
|
| Pelvic Neoplasms | 1 | 1985 | 250 | 0.010 |
Why?
|
| Female | 22 | 2003 | 397464 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8200 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1988 | 1376 | 0.010 |
Why?
|
| Cholecystitis | 1 | 2002 | 181 | 0.010 |
Why?
|
| Portal Vein | 1 | 2003 | 435 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1988 | 1384 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1990 | 2258 | 0.010 |
Why?
|
| Aged | 17 | 2003 | 171790 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1988 | 1397 | 0.010 |
Why?
|
| Retrospective Studies | 10 | 2003 | 81892 | 0.010 |
Why?
|
| Arteriosclerosis | 2 | 1975 | 1056 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2003 | 14751 | 0.010 |
Why?
|
| Acute Disease | 3 | 2002 | 7245 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1997 | 79 | 0.010 |
Why?
|
| Angiography | 2 | 1990 | 1598 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 15471 | 0.010 |
Why?
|
| Hospital Charges | 1 | 1998 | 351 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1987 | 1642 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 1985 | 1183 | 0.010 |
Why?
|
| Ultrasonography | 2 | 1986 | 6001 | 0.010 |
Why?
|
| Adult | 14 | 1998 | 223818 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 1990 | 11262 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1995 | 527 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1998 | 1669 | 0.010 |
Why?
|
| Enema | 1 | 1973 | 141 | 0.010 |
Why?
|
| Infarction | 1 | 1973 | 247 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1994 | 993 | 0.010 |
Why?
|
| Galactans | 1 | 1991 | 31 | 0.010 |
Why?
|
| Drainage | 2 | 1988 | 1184 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1994 | 1585 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 1142 | 0.010 |
Why?
|
| Liver Abscess, Amebic | 1 | 1990 | 19 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1975 | 990 | 0.010 |
Why?
|
| Echinococcosis, Hepatic | 1 | 1990 | 23 | 0.010 |
Why?
|
| Radiography | 3 | 1985 | 6991 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1973 | 627 | 0.010 |
Why?
|
| Microcirculation | 1 | 1975 | 1281 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1629 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1973 | 1502 | 0.010 |
Why?
|
| Embolism | 1 | 1973 | 401 | 0.010 |
Why?
|
| Adenoma, Bile Duct | 1 | 1989 | 29 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 1975 | 741 | 0.000 |
Why?
|
| Mice | 2 | 1993 | 82074 | 0.000 |
Why?
|
| Retroperitoneal Space | 1 | 1989 | 173 | 0.000 |
Why?
|
| Hemangioendothelioma | 1 | 1989 | 112 | 0.000 |
Why?
|
| Suppuration | 1 | 1988 | 61 | 0.000 |
Why?
|
| Rats, Inbred WF | 1 | 1987 | 140 | 0.000 |
Why?
|
| Adenoma | 2 | 1989 | 2164 | 0.000 |
Why?
|
| Chemistry | 1 | 1988 | 327 | 0.000 |
Why?
|
| Carcinosarcoma | 1 | 1989 | 108 | 0.000 |
Why?
|
| Pancreatic Ducts | 1 | 1990 | 330 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1988 | 486 | 0.000 |
Why?
|
| Aged, 80 and over | 4 | 1995 | 59738 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1987 | 575 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1990 | 773 | 0.000 |
Why?
|
| Syndrome | 1 | 1973 | 3274 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1985 | 9442 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2003 | 13054 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1989 | 1154 | 0.000 |
Why?
|
| Prospective Studies | 3 | 1997 | 54950 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20244 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1987 | 963 | 0.000 |
Why?
|
| Magnetics | 1 | 1988 | 599 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 1998 | 39394 | 0.000 |
Why?
|
| Length of Stay | 1 | 1998 | 6525 | 0.000 |
Why?
|
| Observer Variation | 1 | 1990 | 2623 | 0.000 |
Why?
|
| Leiomyoma | 1 | 1989 | 644 | 0.000 |
Why?
|
| Random Allocation | 1 | 1987 | 2396 | 0.000 |
Why?
|
| Cicatrix | 1 | 1989 | 799 | 0.000 |
Why?
|
| United States | 1 | 1991 | 73180 | 0.000 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1990 | 933 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1990 | 2916 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1987 | 735 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1990 | 3629 | 0.000 |
Why?
|
| Necrosis | 1 | 1986 | 1621 | 0.000 |
Why?
|
| Logistic Models | 1 | 1994 | 13317 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1998 | 7472 | 0.000 |
Why?
|
| Thrombosis | 1 | 1973 | 2956 | 0.000 |
Why?
|
| Carcinoma | 1 | 1990 | 2340 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1990 | 2055 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1990 | 4428 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1990 | 10778 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1975 | 53 | 0.000 |
Why?
|
| Papaverine | 1 | 1975 | 45 | 0.000 |
Why?
|
| Injections, Intra-Arterial | 1 | 1975 | 181 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1988 | 8742 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1990 | 19023 | 0.000 |
Why?
|
| Mesentery | 1 | 1975 | 202 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 8055 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1987 | 4300 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1994 | 13593 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1988 | 18366 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 21187 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1989 | 42684 | 0.000 |
Why?
|
| Adolescent | 1 | 1994 | 89247 | 0.000 |
Why?
|
| Time Factors | 1 | 1985 | 40266 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1985 | 15889 | 0.000 |
Why?
|
| Child | 1 | 1989 | 80969 | 0.000 |
Why?
|
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_